Posts by Sandra Ansanay-Alex
Future Health Lausanne, an opportunity for the Swiss Health Valley
Future Health Lausanne is taking place on 3 October 2023 at the Swisstech Convention Center in Lausanne. The event is a real opportunity to bring together the regional life sciences ecosystem according to Magali Bischof, BioAlps’ Secretary General. Tell us more about the translation ecosystem in the region? The Swiss Health Valley is home…
Read MoreAdiposs SA announced the completion of the phase I clinical trial of its ImageBAT™
Adiposs SA, a Swiss biotech company developing medical imaging products and technologies, announced the completion of the phase I clinical trial of its flagship product, ImageBAT™, a medical imaging product Thirty healthy subjects were given single ascending doses of ImageBAT™. The product demonstrated good tolerability and safety with no serious or severe adverse…
Read MoreA consortium led by Addex Therapeutics secures a €4 million Eurostars grant
The Geneva-based pharmaceutical company will use the grant to support its programme for mild neurocognitive disorders (mNCD). The project, called COGNI+, aims to develop clinical candidates ready for IND enabling studies and is led by a consortium that includes Naason Science (South Korea), BioAxis Research (Netherlands), Pharmidex Pharmaceutical Services (UK), and Stichting Radboud…
Read MoreMultiwave raises CHF 3.8 Million
Geneva-based deeptech startup Multiwave Technologies SA, led by Tryfon and Panos Antonakakis, is attracting new capital that will be dedicated to securing FDA approval for the world’s lightest portable magnetic resonance imaging (MRI) device. Swiss medical technology company Multiwave raised a total of CHF 3.8 million in two consecutive capital increases in July…
Read MoreSwiss Cancer Center Léman found a way to boost artificial immune cells to fight cancer
A team of Swiss researchers has discovered a way of prolonging the efficacy of CAR-T cells in immunotherapy for the treatment of certain blood cancers. CAR-T cells are T lymphocytes modified in the laboratory to specifically target cancer cells. However, their effectiveness rapidly diminishes in many patients. Researchers have identified a metabolic mechanism common…
Read MoreLonza to stop producing Moderna vaccine in Visp
Production of the Moderna serum will cease at Visp in the canton of Valais. In addition, Lonza’s Managing Director, Pierre-Alain Ruffieux, is stepping down and will be replaced ad interim by Albert Baehny, 71. Pierre-Alain Ruffieux, CEO of Lonza since 1 November 2020, will down from his post at the beginning of October, Albert…
Read MoreSocorex, 60 years of success in precision volumetry
The story begins in 1963, in Canton of Vaud (Switzerland) with the know-how gathering of small companies active in manufacturing medical and dental syringes, needles and cannulas. Thanks to a new production site in Ecublens and a consolidated range of reliable, robust medical instruments and accessories, Socorex quickly became a success on the Swiss and…
Read MoreCUTISS AG launches its Series C funding round
CUTISS AG, a Swiss company specialising in regenerative skin medicine and tissue engineering, has announced the launch of its Series C funding round. This milestone aims to support the development of its personalised skin therapy, denovoSkin™, following successful Phase 2 clinical trials. CUTISS also plans to finalise the clinical preparation of an automated machine…
Read MoreAmal Therapeutics wins Geneva Innovation Prize
Les Grands Prix de l’économie 2023 are organised by the CCIG, with the support of the State of Geneva and the Office de Promotion des Industries et des Technologies (OPI). The Innovation Prize went to Amal Therapeutics, which specialises in cancer treatment and prevention. This spin-off from the University of Geneva and the…
Read MoreA new brain cell discovered by Swiss researchers
The two major families of cells that make up the brain, neurons and glial cells, secretly hid a hybrid cell, halfway between these two categories. The discovery, made by a team of University of Lausanne (UNIL) and Wyss Center for Neuro and Bio Engineering in Geneva, could transform our understanding of brain function and dysfunction.…
Read More